TUCSON, Ariz., Sept. 30, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an innovator of rapid in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has ...
Rapid microbial identification in blood cultures has transformed the management of bloodstream infections by substantially reducing the time between sample positivity and pathogen identification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results